Guardant Health
297 hedge funds and large institutions have $3.65B invested in Guardant Health in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 95 increasing their positions, 90 reducing their positions, and 32 closing their positions.
97% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 32
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
28% more capital invested
Capital invested by funds: $2.86B → $3.65B (+$792M)
10% more funds holding
Funds holding: 270 → 297 (+27)
6% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 90
6.82% less ownership
Funds ownership: 103.53% → 96.71% (-6.8%)
48% less call options, than puts
Call options by funds: $29.5M | Put options by funds: $56.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$39.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$32.4M |
| 3 |
Two Sigma Advisers
New York
|
+$32M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.6M |
| 5 |
Millennium Management
New York
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$148M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$48.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$42.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$20.6M |
GH Hedge Fund Activity: Q4 2024 in Review
297 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2024, worth a combined $3.65B — up 28% from $2.86B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new GH positions and 32 closed out — a net gain of 31 holders — while 95 added to existing stakes and 90 trimmed.
The largest buyer was UBS Group, adding an estimated $39.2M. The largest seller was Wellington Management Group, cutting an estimated $148M.
- 297 institutional investors held Guardant Health (GH) as of Q4 2024, up from 270 in Q3 2024.
- Funds reported $3.65B of Guardant Health stock for Q4 2024, up 28% quarter-over-quarter.
- 63 funds opened new Guardant Health positions in Q4 2024 and 32 closed out, a net change of +31 holders.
- The largest Guardant Health buyer in Q4 2024 was UBS Group, an estimated $39.2M added.
- The largest Guardant Health seller in Q4 2024 was Wellington Management Group, an estimated $148M sold.
Based on aggregated 13F filings for Q4 2024.